Skip to main content

The ISN Clinical Research Program supports research and education programs in low-to-middle income countries, involving local nephrologists, health workers and authorities. The Program helps implement research projects to detect and manage non-communicable chronic diseases such as CKD, hypertension, diabetes and cardiovascular disease.


Download the detailed Clinical Research Program Guidelines 
If you satisfy all criteria, you can register and create your application.

There are two rounds each year for submission of the proposals with the following deadlines (at 10 p.m., Central Europe Time): May 1st and October 1st .

What types of studies are funded?
Three types of studies are funded under the Clinical Research Program:
  • Screening and intervention studies: these studies identify individuals at high risk for or with chronic kidney disease by screening programs. They should be complemented by patient follow-up programs through medical management including health education, lifestyle modification and pharmacological treatment in order to reduce end-stage kidney and cardiovascular disease and mortality.
  • Clinical local research studies addressing specific local needs: these are small clinical research projects aimed to address specific needs at the local regional/country level. Projects should be related to acute and chronic kidney disease.
  • Acute Kidney Injury studies: A special priority will be given to projects that focus on clinical aspects of Acute Kidney Injury (AKI) in low and middle income countries - especially studies on epidemiology, risk factors, prevention and treatment and this to be in line with the 0by25 ISN human rights initiative     
What are the deadlines for applying?
There are two application rounds each year for submission of the project proposals; the application deadlines are on May 1 and October 1 of every year. The announcement of the awarded projects will be in August and January, respectively.

What are the eligibility criteria to get funding?
  1. Applicants must be ISN members.
  2. Applications must be approved before submission by ISN’s Regional Coordinators, who survey the activities of the prevention programs on a regional level. The Regional Coordinators help applicants to prepare their applications before submission.
  3. Prospective applicants must contact their ISN Regional Coordinator a minimum of 1 month before the submission deadline
What is the evaluation process? 
Projects that have been approved by ISN’s Regional Coordinators and evaluated by an independent and geographically representative ISN Selection Committee (Members of the Clinical Research Committee) will receive partial seed funding for the set-up of the local program.

The first three to four ranked projects in each round are awarded a 10,000 to 20,000 USD grant for setting up the local program.